Business · 09/04/2003Updated: 10/17/2026 · 1 min read
US Patent Office Extends Patent for Poulvac ST Vaccine
Summary
The US Patent and Trademark Office has determined the regulatory review period for the Poulvac ST Vaccine, allowing the patent to be extended for a veterinary biologic product.
Original source language: Federal Register — Agriculture DepartmentOpen original release →